Welcome to Current Partnering – life science intelligence for deal makers

We are the publisher of CP Reports – life science deal term reports. We also produce Current Agreements – the leading comprehensive partnering, M&A, financing and company database.

In addition, we offer CP Insight – an interactive platform for an advanced level of deal making intelligence, and CP Knowledge Centre – our 3-in-1 life science intelligence package – ideal for users who need comprehensive access to all that Current Partnering has to offer.

New report

Provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies. More

 

Featured partnering deals

Roche forms a pharma alliance with AmorChem

July 30, 2014 : big pharma, pharma alliances, pharma licensing, Roche

Roche and AmorChem announced they have entered into a pharma alliance to discover novel small molecule disease-modifying therapy for the treatment of myotonic muscular dystrophy 1, or Steinert’s disease. more »

AstraZeneca signs pharma deal with Qiagen

July 29, 2014 : AstraZeneca, big pharma, partnering, pharma alliances, pharma deals

AstraZeneca has entered into a pharma deal with  QIAGEN to develop a non-invasive diagnostic test to identify non-small cell lung cancer (NSCLC) patients who are suitable for treatment with IRESSA. more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Rothapharm signs for a m&a with Meda

August 1, 2014 : acquisition, M&A, meda

Meda has entered into a definitive m&a agreement to acquire Rottapharm-Madaus for $3.08 billion. more »

Big pharma, Pfizer buys a small stake in Cellectis

August 1, 2014 : acquisition, M&A

Pfizer, a big pharma, has acquried 10% stake in Cellectis.  more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Gen9 raises $25 million in equity financing

August 1, 2014 : financing, financings

Gen9 has filed for the receipt of $25 million in equity financing. more »

Epic sciences gets $30 million in series C financing

July 31, 2014 : big biotech, big pharma, financing, financings

Epic Sciences announced the completion of a $30 million Series C Preferred Stock financing. more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Reckitt Benckiser spins off its pharmaceutical division

July 29, 2014 : consumer healthcare, pharma, spin-out

Reckitt Benckiser, the consumer goods giant that makes Nurofen and Dettol, plans to spin off its US-based pharmaceutical business.
more »

Biotech rumour mill has it that Siemens plans for a spin off

July 15, 2014 : dealtalk, spin-out

Rumour mill has it that Siemens is reportedly investigating a spinout of its Siemens Healthcare division’s IT unit, which could be worth more than $1 billion. more »

 More dealtalk

Featured reports

Co-development Terms and Agreements

Publication date: August 2014

Personalized Medicine in Oncology Partnering Terms and Agreements

Publication date: August 2014

Licensing Terms and Agreements

Publication date: August 2014

Trends in Therapeutic Partnering

Publication date: August 2014

Cancer Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Co-promotion & Co-marketing Partnering Terms and Agreements

Publication date: July 2014

Drug Delivery Terms and Agreements

Publication date: July 2014

Vaccine Partnering Terms and Agreements

Publication date: July 2014

Distribution Partnering Terms and Agreements

Publication date: July 2014

Diagnostics Partnering Terms and Agreements

Publication date: July 2014

Pharma and Biotech M&A Trends 2009-2014

Publication date: July 2014

Infectious Vaccines Partnering Terms and Agreements

Publication date: June 2014

Antibiotics Partnering Terms and Agreements

Publication date: June 2014

NEW: Therapy deal reports covering all major indications

Including partnering in oncology, cardiovascular, CNS, metabolic, dermatology, dental, infectives, immunologypsychiatry, genitourinary.....plus many others

View all reports

Scorecard

Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:

Partnering

M&A

Financing

Top 50 pharma partnering

Top 50 biotech partnering

Top pharma R&D spend

Deal metrics - by stage of development, therapy area, industry sector

Print Friendly
bannerpng
RSS Feed Linked In Twitter

Latest Tweets

ca300x150gif
current-partnering-300x150jpg
epicbanner1landscapejune11jpg